|
JAMA Oncology |
Long-term Immunogenicity of BNT162b2 Vaccine in Patients With Solid Tumors |
1 |
Yes |
4/22/2025 |
|
JAMA Oncology |
Management of Cutaneous Immune-Related Adverse Events in Patients With Cancer Treated With Immune Checkpoint Inhibitors |
1 |
Yes |
1/20/2025 |
|
JAMA Oncology |
Management of Cutaneous Immune-Related Adverse Events in Patients With Cancer Treated With Immune Checkpoint Inhibitors - A Systematic Review |
1 |
Yes |
1/20/2025 |
|
JAMA Oncology |
Management of Down Syndrome Associated Leukemias - A Review |
1 |
Yes |
7/13/2024 |
|
JAMA Oncology |
Neoadjuvant Endocrine Therapy in Clinical Practice |
1 |
Yes |
11/18/2024 |
|
JAMA Oncology |
Neoadjuvant Endocrine Therapy in Clinical Practice - A Review |
1 |
Yes |
11/18/2024 |
|
JAMA Oncology |
Oral Mucosal Pigmentation in a Patient With Mycosis Fungoides |
1 |
Yes |
8/10/2026 |
|
JAMA Oncology |
Painful Eruptions in a Patient With Cholangiocarcinoma Treated With Fibroblast Growth Factor Receptor Inhibitor |
1 |
Yes |
10/28/2024 |
|
JAMA Oncology |
SARS-CoV-2 Antibody Response to 2 or 3 Doses of the BNT162b2 Vaccine in Patients Treated With Anticancer Agents |
1 |
Yes |
1/14/2025 |
|
JAMA Oncology |
SARS-CoV-2 Antibody Response to 2 or 3 Doses of the BNT162b2 Vaccine in Patients Treated With Anticancer Agents |
1 |
Yes |
1/14/2025 |
|
JAMA Oncology |
SARS-CoV-2 Spike-Specific T-Cell Responses in Patients With B-Cell Depletion Who Received Chimeric Antigen Receptor T-Cell Treatments |
1 |
Yes |
11/24/2024 |
|
JAMA Oncology |
SARS-CoV-2 Spike-Specific T-Cell Responses in Patients With B-Cell Depletion Who Received Chimeric Antigen Receptor T-Cell Treatments |
1 |
Yes |
11/24/2024 |
|
JAMA Oncology |
Scattered Painful Papulonodules in an Older Woman |
1 |
Yes |
7/20/2026 |
|
JAMA Oncology |
Serologic Status and Toxic Effects of the SARS-CoV-2 BNT162b2 Vaccine in Patients Undergoing Treatment for Cancer |
1 |
Yes |
8/4/2024 |
|
JAMA Oncology |
Serologic Status and Toxic Effects of the SARS-CoV-2 BNT162b2 Vaccine in Patients Undergoing Treatment for Cancer |
1 |
Yes |
8/4/2024 |
|
JAMA Oncology |
Subacute Abdominal Pain in a Patient With Chronic Liver Disease and Hepatocellular Carcinoma |
1 |
Yes |
9/22/2025 |
|
JAMA Oncology |
Time-Dependent COVID-19 Mortality in Patients With Cancer - An Updated Analysis of the On Covid Registry |
1 |
Yes |
11/24/2024 |
|
JAMA Oncology |
Time-Dependent COVID-19 Mortality in Patients With Cancer - An Updated Analysis of the OnCovid Registry |
1 |
Yes |
11/24/2024 |
|
JAMA Oncology |
Time-Dependent COVID-19 Mortality in Patients With CancerAn Updated Analysis of the On Covid Registry |
1 |
Yes |
11/24/2024 |
|
JAMA Oncology |
Time-Related Biases in Nonrandomized COVID-19 Era Studies Using Real-world Data |
1 |
Yes |
6/21/2024 |
